Skip to main content
TipRanks
Go Ultimate75% OFF

American Shared Hospital Services (AMS) AI Stock Analysis

135 Followers
AMS

American Shared Hospital Services

(NYSE MKT:AMS)

Select Model
Rating:48Neutral
Price Target:$1.00â–¼(-7.41% Downside)
Action:reiterated
Date:11/14/26

The overall score of 48 reflects a company with a solid financial foundation but facing significant operational and market headwinds. The primary support comes from a strong, deleveraged balance sheet and robust cash flow generation, which provide a critical buffer. However, this is heavily offset by severe profitability issues, including margin compression and net losses, as highlighted in both financial statements and the earnings call. The stock's bearish technical trend and negative P/E ratio further weigh on the score, indicating a high-risk profile with limited near-term positive catalysts until profitability stabilizes.

Positive Factors
Revenue and direct patient services growthRevenue growth is supported by expanding Direct Patient Services, Rhode Island radiation therapy operations, and international Gamma Knife activity. This indicates improving utilization of AMS’s installed treatment platform and can strengthen recurring procedure-linked revenue over the next several quarters.
Negative Factors
Material margin compression and continuing lossesThe sharp decline in gross margin and widening net loss show that revenue growth is not yet converting efficiently into earnings. Persistent cost pressure, higher operating expenses, and weaker EBITDA could constrain reinvestment and make future growth less valuable until margins recover.

American Shared Hospital Services (AMS) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%AMS-49.06%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$7.18M
Dividend Yield
―
Average Volume (3M)
10.54K
Price to Earnings (P/E)
-3.2
Beta (1Y)
0.25
Revenue Growth
4.90%
EPS Growth
-3.41%
Country
US
Employees
83
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

American Shared Hospital Services Business Overview & Revenue Model

Company Description

American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditio...

How the Company Makes Money

AMS primarily makes money by enabling hospitals and treatment centers to provide advanced radiation therapy without those providers bearing the full upfront burden of owning and operating the technology. Its revenue model typically centers on long-te...

American Shared Hospital Services Earnings Call Summary

Earnings Call Date:Nov 12, 2026(Q3-2026)|% Change Since:-8.47%|Next Earnings Date:May 11, 2020
Earnings Call SentimentNeutral

The call presented meaningful operational and revenue growth, particularly in Direct Patient Services, international Gamma Knife procedures, cash generation and development opportunities. However, profitability weakened, with lower gross margins and EBITDA, higher legal and consulting expenses, widening net losses, lower procedure volumes at certain facilities and continued reliance on resolving creditor and capital-structure matters. The overall tone was mixed, with management expressing confidence in the company’s growth prospects while acknowledging significant financial and operational challenges.

Positive Updates

Strong Nine-Month Revenue Growth
Total revenue increased 13.7% to approximately $23.1 million in the first nine months of fiscal 2026 from approximately $20.3 million in the prior-year period. Third-quarter revenue increased 6.3% to approximately $7.6 million from approximately $7.2 million.

Negative Updates

Lower Third-Quarter Gross Profit and Gross Margin
Third-quarter gross profit declined to approximately $1.5 million from approximately $1.6 million in the prior-year period. Gross margin decreased to 19.9% from 22.1%.

Company Guidance

Management said it remains focused on driving continued revenue growth, increasing utilization, improving operating efficiency, managing costs, improving operating cash flow and expanding its installed base of advanced radiation therapy technologies. The company currently expects the Hospital San Javier facility in Guadalajara, Mexico, to begin treating patients in mid-2027 and expects to be operational in mid-2027; the upgraded Gamma Knife would be 1 of only 3 Gamma Knives in the country of Mexico. The proton beam system project is pursuing an asset-light philosophy, while the Bristol, Rhode Island linear accelerator and Johnston, Rhode Island proton beam system projects are in the design phase with not much CapEx incurred quite yet. Management said it feels there's still opportunity to improve gross margins, and when banking, legal and consulting costs go away, it should improve operating margin levels. The company generated approximately $5.8 million of cash from operations in the first nine months, had $9.5 million of cash against roughly $15 million of indebtedness with Fifth Third, and has a forbearance agreement through June 30, 2027.

American Shared Hospital Services Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is strong with low debt (D/E 0.18) and the cash flow is robust ($6.9M TTM FCF), providing a safety net. However, the income statement is weak, with collapsing gross margins (16.7% TTM) and significant net losses (-$2.4M TTM) despite strong revenue growth. The cash flow strength offsets some income statement weakness.

Income Statement

35Negative

Balance Sheet

72Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue30.87M28.08M28.34M21.32M19.75M17.63M
Gross Profit5.15M5.04M9.19M9.34M8.38M6.73M
EBITDA2.61M4.07M8.91M6.97M8.11M6.97M
Net Income-2.38M-1.55M2.19M610.00K1.33M194.00K
Balance Sheet
Total Assets52.87M55.48M60.20M48.16M43.96M45.43M
Cash, Cash Equivalents and Short-Term Investments9.48M3.46M11.03M13.69M12.34M8.14M
Total Debt4.10M22.61M23.23M17.64M14.31M17.47M
Total Liabilities27.84M27.79M30.17M21.88M18.33M21.19M
Stockholders Equity22.61M24.03M25.18M22.62M21.63M19.89M
Cash Flow
Free Cash Flow6.91M-4.54M-7.77M-555.00K6.85M4.59M
Operating Cash Flow5.10M3.10M167.00K5.72M7.24M6.27M
Investing Cash Flow1.81M-7.63M-7.11M-6.27M-388.00K-1.67M
Financing Cash Flow-2.77M-3.03M4.41M1.91M-2.66M-655.00K

American Shared Hospital Services Technical Analysis

Technical Analysis SentimentNegative
Last Price1.08

Price Trends

50DMA1.33Negative
100DMA1.41Negative
200DMA1.57Negative

Market Momentum

MACD-0.06Positive
RSI27.88Positive
STOCH28.88Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Negative. The current price of 1.08 is below the 20-day moving average (MA) of 1.22, below the 50-day MA of 1.33, and below the 200-day MA of 1.57, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 27.88 is Positive, neither overbought nor oversold. The STOCH value of 28.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMS.

American Shared Hospital Services Risk Analysis

American Shared Hospital Services disclosed 25 risk factors in its most recent earnings report. American Shared Hospital Services reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The Company's failure to file certain financial statements in connection with the RI Acquisition pursuant to Rules 8-04 and 8-05 of Regulation S-X and Item 9.01 of Form 8-K will limit the Company's ability to raise capital.Q2, 2024
2.The trading volume of the Company's common stock is lowQ4, 2023
3.Flaws in the Company's ongoing due-diligence assessment in connection with the equity interests and payor contracts to be acquired in the RI Acquisition could have a significant negative effect on the Company's financial condition and results of operations.Q4, 2023

American Shared Hospital Services Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AMS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
PACSPACS71Outperform$7.67B27.6125.77%―11.02%62.56%
ARDTARDT68Neutral$2.51B17.119.48%―2.03%-28.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SGRYSGRY51Neutral$3.53B-40.22-5.17%―2.19%50.06%
AMSAMS48Neutral$7.18M-3.18-10.19%―4.90%-3.41%
CYHCYH44Neutral$315.90M8.30-2.51%―-7.84%-88.93%
CCMCCM40Underperform$15.72M-0.035.16%―20.26%69.68%

* Healthcare Sector Average

Performance Comparison

0%100%200%AMSCYHCCMSGRYPACSARDTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AMS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AMSAmerican Shared Hospital Services1.08-1.08-50.00%
CYHCommunity Health Systems2.24-0.77-25.58%
CCMConcord Medical Services3.62-0.68-15.81%
SGRYSurgery Partners Inc.26.9511.8978.95%
PACSPACS Group Inc48.3232.62207.77%
ARDTArdent Health Partners, Inc.17.809.52114.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026